Literature DB >> 24314681

Activities of daily living: evaluation and treatment in persons with multiple sclerosis.

Ann Buzaid1, Mary Pat Dodge, Lynne Handmacher, Pamela J Kiltz.   

Abstract

Symptoms of multiple sclerosis can create mild to severe changes in a person's abilities to perform activities of daily living. Occupational therapy assessment and treatment of impairments related to movement, sensory-related symptoms, fatigue, and cognitive impairments can have a significant impact on the quality of life of persons with multiple sclerosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADL; Activities of daily living; Adaptive equipment; Home safety; Multiple sclerosis; Occupational therapy

Mesh：

Year:  2013        PMID： 24314681     DOI： 10.1016/j.pmr.2013.06.008

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN： 1047-9651            Impact factor:   1.784


  4 in total

1.  The association between cognition and motor performance is beyond structural damage in relapsing-remitting multiple sclerosis.

Authors:  Damiano Mistri; Laura Cacciaguerra; Loredana Storelli; Alessandro Meani; Claudio Cordani; Maria A Rocca; Massimo Filippi
Journal:  J Neurol       Date:  2022-03-12       Impact factor: 6.682

2.  A Systematic Review of Nonpharmacological Interventions for Moderate to Severe Dementia: A Study Protocol for a Systematic Review and Meta-Analysis.

Authors:  Riyoung Na; You Joung Kim; Kiwon Kim; Ki Woong Kim
Journal:  Psychiatry Investig       Date:  2018-03-26       Impact factor: 2.505

Review 3.  Occupational Therapy in Fatigue Management in Multiple Sclerosis: An Umbrella Review.

Authors:  Angela Salomè; Tullia Sasso D'Elia; Giorgia Franchini; Valter Santilli; Teresa Paolucci
Journal:  Mult Scler Int       Date:  2019-03-21

4.  The effect of applying the nursing process based on the Theory of Goal Attainment on activities of daily living and quality of life in persons with multiple sclerosis during COVID-19 pandemic: a clinical trial.

Authors:  Firuzeh Payamani; Mahnaz Khatiban; Alireza Soltanian; Masoud Ghiasian; Seyed Reza Borzou
Journal:  Ir J Med Sci       Date:  2022-07-25       Impact factor: 2.089
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.